FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386862002: Isradipine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461040018 Isradipine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1480977014 Isradipine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
367101000195115 isradipina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
819201000172111 isradipine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Isradipine (substance) Is a Calcium channel blocker false Inferred relationship Some
Isradipine (substance) Is a Dihydropyridine derivative calcium channel blocker true Inferred relationship Some
Isradipine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Calcium channel blocker (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing isradipine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isradipine (substance) Inferred relationship Some 1
Isradipine adverse reaction Causative agent (attribute) True Isradipine (substance) Inferred relationship Some 1
Allergy to isradipine Causative agent (attribute) False Isradipine (substance) Inferred relationship Some
Isradipine 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some
Product containing precisely isradipine 2.5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some
Product containing precisely isradipine 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some
Isradipine 5mg controlled release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some
Isradipine 10mg controlled release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some
Isradipine m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some
Isradipine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isradipine (substance) Inferred relationship Some 1
Allergy to isradipine Causative agent (attribute) True Isradipine (substance) Inferred relationship Some 1
Isradipine 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some 1
Isradipine 2.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isradipine (substance) Inferred relationship Some 1
Product containing precisely isradipine 2.5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some 1
Product containing precisely isradipine 2.5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isradipine (substance) Inferred relationship Some 1
Product containing precisely isradipine 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some 1
Product containing precisely isradipine 5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isradipine (substance) Inferred relationship Some 1
Isradipine 5mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isradipine (substance) Inferred relationship Some
Product containing precisely isradipine 2.5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isradipine (substance) Inferred relationship Some 1
Product containing precisely isradipine 5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isradipine (substance) Inferred relationship Some 1
Isradipine 2.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isradipine (substance) Inferred relationship Some 1
Isradipine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isradipine (substance) Inferred relationship Some 1
Product containing only isradipine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isradipine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start